Pulse Biosciences (PLSE) had the highest return between March 31, 2023 and April 30, 2023 by a small-cap US stock, returning 131.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pulse Biosciences (PLSE) | 3/31/2023 - 4/30/2023 | 131.65% |
National CineMedia (NCMI) | 3/31/2023 - 4/30/2023 | 116.47% |
SS Innovations International Inc Common Stock (SSII) | 3/31/2023 - 4/30/2023 | 116.22% |
Eyepoint Pharmaceuticals (EYPT) | 3/31/2023 - 4/30/2023 | 96.25% |
Trevi Therapeutics (TRVI) | 3/31/2023 - 4/30/2023 | 87.98% |
Sana Biotechnology (SANA) | 3/31/2023 - 4/30/2023 | 69.01% |
Tourmaline Bio (TRML) | 3/31/2023 - 4/30/2023 | 60.89% |
Akebia Ther (AKBA) | 3/31/2023 - 4/30/2023 | 59.39% |
Phathom Pharmaceuticals (PHAT) | 3/31/2023 - 4/30/2023 | 56.2% |
Xeris Pharmaceuticals (XERS) | 3/31/2023 - 4/30/2023 | 55.86% |
Collective Mining (CNL) | 3/31/2023 - 4/30/2023 | 53.99% |
American Coastal Insurance (ACIC) | 3/31/2023 - 4/30/2023 | 50.73% |
Magnera Corp placeholder (MAGN) | 3/31/2023 - 4/30/2023 | 47.23% |
IperionX Limited American Depositary Share (IPX) | 3/31/2023 - 4/30/2023 | 46.22% |
Oculis Holding AG Ordinary shares (OCS) | 3/31/2023 - 4/30/2023 | 44.55% |
Brookdale Senior Living (BKD) | 3/31/2023 - 4/30/2023 | 42.52% |
Beazer Homes USA (BZH) | 3/31/2023 - 4/30/2023 | 39.1% |
Annexon (ANNX) | 3/31/2023 - 4/30/2023 | 37.79% |
Bright Minds Biosciences (DRUG) | 3/31/2023 - 4/30/2023 | 36.74% |
Bit Digital (BTBT) | 3/31/2023 - 4/30/2023 | 36.55% |
UroGen Pharma (URGN) | 3/31/2023 - 4/30/2023 | 36.51% |
Y mAbs Therapeutics (YMAB) | 3/31/2023 - 4/30/2023 | 36.45% |
Corvus Pharmaceuticals (CRVS) | 3/31/2023 - 4/30/2023 | 36.42% |
Olema Pharmaceuticals (OLMA) | 3/31/2023 - 4/30/2023 | 34.55% |
Sequans Communications (SQNS) | 3/31/2023 - 4/30/2023 | 33.49% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
